ARTICLE OF THE MONTH
TOP ARTICLES
A scoping review of reversible cerebral encephalopathy syndromes following blood transfusion in the settings of anemia and clinical recommendations
Ali HT, Nouh Y, Obadi A, Habib I, Abutawahina K, et al. Neurol Sci. 2026 Sep 17;47(10).
Intravenous Immunoglobulin Add-On in Newly Diagnosed Idiopathic Inflammatory Myopathies: A Randomized Clinical Trial
Özkaynar P, Evers S, Kamperman R, Smithuis F, Eftimov F, et al. JAMA Neurol. 2026 Sep 14.
Low-dose baricitinib plus danazol in primary immune thrombocytopenia: a randomized, controlled phase 2 trial.
Zhao, P., et al. (2026). Nature Communications.
AINAR trial: A randomized controlled trial to assess the usefulness of artificial intelligence-based game to conquer needle fear in blood donors
Meher R, Patidar GK. Transfus Clin Biol. 2026 Sep 7.
Efficacy and safety of thalidomide (1 vs 2 mg/kg/d) in transfusion-dependent thalassemia: A Non-Inferiority Trial
Kakkar S, Mahajan A, Sharma RA, Radhakrishnan N, Manglani M, et al. Blood Adv. 2026 Sep 1.
Intravenous ferric carboxymaltose and exercise capacity in iron-deficient kidney transplant recipients: a randomised, placebo-controlled trial in the Netherlands
Vinke JSJ, Eisenga MF, van der Vaart A, van Lieshout CJ, Dolmans HWGM, et al. EClinicalMedicine. 2026 Sep 1;99:104169.
Minimizing blood sampling in preterm infants
Nissimov S, Sibrecht G, Weerasekara I, Bartocci M, Bruschettini M, et al. Cochrane Database Syst Rev. 2026 Aug 26;8(8).
A Phase IIa, Double Blind, Randomized, Placebo Controlled, Parallel, Multicentre, Proof-of-Concept Study to Evaluate the Efficacy and Safety of Desidustat Oral Tablet for Treatment of Sickle Cell Disease
Desai M, Solanki B, Hathila M, Asati V, Shah S, et al. Eur J Haematol. 2026 Aug 25.
Continuation versus discontinuation of intravenous oxytocin in the active phase of labour
Boie S, Uldbjerg N, Bor P, Thornton JG, Le Ray C, et al. Cochrane Database Syst Rev. 2026 Aug 25;8(8).
No comments:
Post a Comment